Metabolic syndrome is a predictor of all site and liver-specific recurrence following primary resection of colorectal cancer: Prospective cohort study of 1006 patients
Publication date: Available online 7 January 2021Source: European Journal of Surgical OncologyAuthor(s): Rahul Bhome, Nadia Peppa, Shoura Karar, Declan McDonnell, Alex Mirnezami, Zaed Hamady
Source: European Journal of Surgical Oncology (EJSO) - Category: Surgery Source Type: research
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Liver | Metabolic Syndrome | Study | Surgery | Urology & Nephrology